Skip to main content

Sequential paracrine mechanisms are necessary for the therapeutic benefits of stem cell therapy.

Publication ,  Journal Article
Sun, H; Pratt, RE; Hodgkinson, CP; Dzau, VJ
Published in: Am J Physiol Cell Physiol
December 1, 2020

Stem cell injections are an attractive therapeutic tool. It has been demonstrated that injected stem cells promote tissue repair and regeneration via paracrine mechanisms. However, the effects of injected stem cells continue for far longer than they are present. We hypothesized that the effects of injected stem cells are prolonged because of a sequential paracrine relay mechanism. Conditioned media was collected from mesenchymal stem cells (MSCs) after 24 h. This media was then added to RAW264.7. Media was collected from the macrophages after 24 h and was then added to endothelial cells (ECs). This conditioned macrophage media, but not control media, promoted wound healing and induced EC differentiation. Similar results were observed with primary macrophages. To identify the active paracrine factors released by macrophages in response to stimulation by MSC conditioned media we used an antibody array, identifying increased expression of the angiogenesis-related proteins stromal cell-derived factor 1 (SDF1) and plasminogen activator inhibitor-1 (PAI-1). Knockdown of either protein inhibited the ability of conditioned media derived from MSC paracrine factor-stimulated macrophages to induce EC differentiation both in vitro and in vivo. Conditioned media derived from postnatal day 7 (P7) mouse macrophages induced EC differentiation. Moreover, SDF1 and PAI-1 levels were >120 higher in P7 macrophages compared with adult macrophages, suggesting that MSC paracrine factors promote adult macrophages to adopt a juvenile phenotype. These results indicate that MSC paracrine factors induce macrophages to secrete SDF1 and PAI-1, in-turn inducing endothelial cells to differentiate. Identification of a sequential paracrine mechanism opens new therapeutic avenues for stem cell therapy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Physiol Cell Physiol

DOI

EISSN

1522-1563

Publication Date

December 1, 2020

Volume

319

Issue

6

Start / End Page

C1141 / C1150

Location

United States

Related Subject Headings

  • Wound Healing
  • Serpin E2
  • RAW 264.7 Cells
  • Physiology
  • Paracrine Communication
  • Neovascularization, Physiologic
  • Mice, Inbred C57BL
  • Mice
  • Mesenchymal Stem Cells
  • Mesenchymal Stem Cell Transplantation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sun, H., Pratt, R. E., Hodgkinson, C. P., & Dzau, V. J. (2020). Sequential paracrine mechanisms are necessary for the therapeutic benefits of stem cell therapy. Am J Physiol Cell Physiol, 319(6), C1141–C1150. https://doi.org/10.1152/ajpcell.00516.2019
Sun, Hualing, Richard E. Pratt, Conrad P. Hodgkinson, and Victor J. Dzau. “Sequential paracrine mechanisms are necessary for the therapeutic benefits of stem cell therapy.Am J Physiol Cell Physiol 319, no. 6 (December 1, 2020): C1141–50. https://doi.org/10.1152/ajpcell.00516.2019.
Sun H, Pratt RE, Hodgkinson CP, Dzau VJ. Sequential paracrine mechanisms are necessary for the therapeutic benefits of stem cell therapy. Am J Physiol Cell Physiol. 2020 Dec 1;319(6):C1141–50.
Sun, Hualing, et al. “Sequential paracrine mechanisms are necessary for the therapeutic benefits of stem cell therapy.Am J Physiol Cell Physiol, vol. 319, no. 6, Dec. 2020, pp. C1141–50. Pubmed, doi:10.1152/ajpcell.00516.2019.
Sun H, Pratt RE, Hodgkinson CP, Dzau VJ. Sequential paracrine mechanisms are necessary for the therapeutic benefits of stem cell therapy. Am J Physiol Cell Physiol. 2020 Dec 1;319(6):C1141–C1150.

Published In

Am J Physiol Cell Physiol

DOI

EISSN

1522-1563

Publication Date

December 1, 2020

Volume

319

Issue

6

Start / End Page

C1141 / C1150

Location

United States

Related Subject Headings

  • Wound Healing
  • Serpin E2
  • RAW 264.7 Cells
  • Physiology
  • Paracrine Communication
  • Neovascularization, Physiologic
  • Mice, Inbred C57BL
  • Mice
  • Mesenchymal Stem Cells
  • Mesenchymal Stem Cell Transplantation